Evidence map›Paper›PMID 16166631›Full record

ArticleMolecular and cellular biology2005

Cbp deficiency alters Csk localization in lipid rafts but does not affect T-cell development.

Shengli Xu, Jianxin Huo, Joy En-Lin Tan, Kong-Peng Lam

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 75 citations in OpenAlex.

  1. Regulation, targets and functions of CSK.Frontiers in cell and developmental biology · 2023
    Review
  2. CSK-mediated signalling by integrins in cancer.Frontiers in cell and developmental biology · 2023
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 3 countries.

Shengli XuLaboratory of Immunology, Center for Molecular Medicine, Institute of Molecular and Cell Biology, 61 Biopolis Drive, Lab 6-15, Proteos, Singapore 138673, Singapore.
Jianxin Huo
Joy En-Lin Tan
Kong-Peng Lam
Institute of Molecular and Cell Biology · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ubiquitously expressed transmembrane adaptor Csk-binding protein (Cbp) recruits Csk to lipid rafts, where the latter exerts its negative regulatory effect on the Src family of protein tyrosine kinases. We have inactivated Cbp in the mouse germ line. In contrast to Csk gene inactivation, which leads to embryonic lethality and impaired T-cell development, Cbp-deficient mice were viable and exhibited normal T-cell development but with an increased thymocyte population. In the absence of Cbp, the amount of Csk that localizes to the lipid rafts was greatly reduced. Interestingly, this altered lipid raft localization of Csk did not lead to any detectable biochemical or functional defect in T cells. The T-cell receptor-induced intracellular calcium flux, cell proliferation, and cytokine secretion were not affected by the absence of Cbp. Peripheral T-cell tolerance to superantigen SEB was also largely intact in Cbp-deficient mice. Thus, Cbp is dispensable for T-cell development and activation.

Indexed as

AnimalsAutoantibodiesCalciumCD4 AntigensCD8 AntigensCell LineCell ProliferationCSK Tyrosine-Protein KinaseDNA, ComplementaryDose-Response Relationship, DrugEndonucleasesEnterotoxinsFlow CytometryImmune ToleranceImmunoglobulin GLymph NodesAutoantibodiesCalciumCD4 AntigensCD8 AntigensCSK Tyrosine-Protein KinaseDNA, ComplementaryEndonucleasesenterotoxin B, staphylococcalEnterotoxinsImmunoglobulin GMembrane ProteinsPag1 protein, mousePhosphoproteinsPhosphotransferasesProtein-Tyrosine KinasesProto-Oncogene Proteinssrc-Family Kinases

Identifiers

PMID16166631
PMCPMC1265734
OpenAlexW2162008308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.